421 related articles for article (PubMed ID: 9525477)
1. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
[TBL] [Abstract][Full Text] [Related]
2. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
Hofbauer LC; Hicok KC; Khosla S
J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
4. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
5. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.
Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR
Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470
[TBL] [Abstract][Full Text] [Related]
6. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
Grant ES; Batchelor KW; Habib FK
Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
[TBL] [Abstract][Full Text] [Related]
7. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
9. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells.
Hickey TE; Marrocco DL; Amato F; Ritter LJ; Norman RJ; Gilchrist RB; Armstrong DT
Biol Reprod; 2005 Oct; 73(4):825-32. PubMed ID: 15972887
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
Justulin LA; Acquaro C; Carvalho RF; Silva MD; Felisbino SL
Int J Androl; 2010 Jun; 33(3):489-99. PubMed ID: 19490185
[TBL] [Abstract][Full Text] [Related]
11. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
Hofbauer LC; Ten RM; Khosla S
J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Dec; 185(3):416-24. PubMed ID: 11056012
[TBL] [Abstract][Full Text] [Related]
13. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells.
Evangelou A; Letarte M; Jurisica I; Sultan M; Murphy KJ; Rosen B; Brown TJ
Cancer Res; 2003 May; 63(10):2416-24. PubMed ID: 12750261
[TBL] [Abstract][Full Text] [Related]
14. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
[TBL] [Abstract][Full Text] [Related]
15. Region-specific expression of androgen and growth factor pathway genes in the rat epididymis and the effects of dual 5alpha-reductase inhibition.
Henderson NA; Cooke GM; Robaire B
J Endocrinol; 2006 Sep; 190(3):779-91. PubMed ID: 17003279
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the regulation of prostatic oxytocin by gonadal steroids in the rat.
Jenkin L; Nicholson HD
J Androl; 1999; 20(1):80-7. PubMed ID: 10100477
[TBL] [Abstract][Full Text] [Related]
18. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B
Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.
Danielpour D; Kadomatsu K; Anzano MA; Smith JM; Sporn MB
Cancer Res; 1994 Jul; 54(13):3413-21. PubMed ID: 8012960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
